VLA2 Integrin Expression in Breast Carcinomas
Author Information
Author(s): C Charpin, S Garcia, D Bergeret, L Andrac, N Horschowski, R Choux, MN Lavaut
Primary Institution: Department of Pathology, Faculte de Medecine Timone; Department of Pathology, Hôpital Nord, Marseille, France
Hypothesis
The study investigates the role of VLA2 integrin in the metastatic process of breast carcinomas.
Conclusion
VLA2 expression in breast carcinomas is independent of most histoprognostic indicators and requires further investigation to determine its clinical relevance.
Supporting Evidence
- VLA2 was positive in 23.5% of the tumors studied.
- VLA2 expression was independent of tumor size, grade, type, and aneuploidy.
- VLA2 significantly correlated with ELAM, VCAM, VLA3, and P-glycoprotein.
Takeaway
This study looked at a protein called VLA2 in breast cancer to see if it helps cancer spread. They found that VLA2 levels didn't really change with other important cancer signs.
Methodology
The study used automated and quantitative immunohistochemistry to evaluate VLA2 expression in frozen tissue sections from breast carcinoma patients.
Potential Biases
Methodological bias may arise from tissue fixation and variations in immunohistochemical methods.
Limitations
The exact role of VLA2 in tumor cell dissemination remains unclear, and the clinical relevance of VLA2 immunodetection requires further investigation.
Participant Demographics
Mean age of participants was 56.4 years, with a range from 32 to 83 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website